Latest filing published 21 Oct 2022 for Milestone Pharmaceuticals Inc., €59k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Michael John Tomsicek: trading record in brief
All filings by Michael John Tomsicek on record concern Milestone Pharmaceuticals Inc. We count 2 filings; the first trade dates from 13 May 2019 and the latest from 19 October 2022.
The open-market record is one-sided, with 1 purchase worth €59k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2022, the count stands at 1 purchase and no sales.
Most recently, on 21 October 2022, the filings show an open-market purchase worth €59k in Milestone Pharmaceuticals Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michael John Tomsicek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,000 shares@ CA$5.3238100.0% of flowCommon SharesTSXSEDI:4020331Canonical exit: 17 Jan 2023 (T+90)
- Common SharesTSXSEDI:3371045
2 of 2 declarations